Skip to main content

TBPH

Theravance Biopharma, Inc.

Company with tickers: TBPH

CIK
1583107
CUSIP
G8807B106
Shares Outstanding
51,553,005
13F Activity (30d)
121 filings 117 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 172
Total Value: $818,687,216
Total Shares: 50,442,843
Showing 1–100 of 178 holdings by value · page 1 of 2

Institutional Ownership Trend

25 quarters

Holder Concentration

Across 172 13F filers · Δ vs Dec 31, 2025
Top Holder
18.9%
Jun 2023 → Mar 2026 · range 14.1% – 26.1%
−0.3 pts
Top 5
57.2%
Jun 2023 → Mar 2026 · range 56.5% – 63.8%
+0.7 pts
Top 10
70.6%
Jun 2023 → Mar 2026 · range 70.3% – 83.1%
+0.3 pts
HHI
828
Jun 2023 → Mar 2026 · range 817 – 1,186
Broadly held−2

Quarterly Activity

vs Dec 31, 2025
New
39
Increased
61
Decreased
46
Sold Out
38
Unchanged
26
Holder count: +1
Institutional value: -12.0%
Shares held: +1.5%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 100 of 178
Export CSV
Holder Value (USD) % of 13F Shares Open